• Karyopharm Therapeutics
• Rain Therapeutics
• Pfizer
• Sanofi
• Incyte Corporation
• Macrogenics
• Adaptimmune
• Merck KGaA
• GlaxoSmithKline
• Novartis Oncology
• Immune Design
• Syndivia
• TerSera Therapeutics
Published | Pages | Publisher | Report code |
---|---|---|---|
Oct 2021 | 60 | DelveInsight | ASDR-574812 |
• Karyopharm Therapeutics
• Rain Therapeutics
• Pfizer
• Sanofi
• Incyte Corporation
• Macrogenics
• Adaptimmune
• Merck KGaA
• GlaxoSmithKline
• Novartis Oncology
• Immune Design
• Syndivia
• TerSera Therapeutics